Dimeticone and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Dimeticone (simethicone), especially for people who are female, 60+ old, also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Dry skin when taking Dimeticone. It is created by eHealthMe based on reports of 759 people who have side effects when taking Dimeticone from the FDA, and is updated regularly.

What is Dimeticone?

Dimeticone has active ingredients of simethicone. eHealthMe is studying from 764 Dimeticone users. Check the latest studies of Dimeticone.

What is Dry skin?

Dry skin is found to be associated with 1,977 drugs and 2,356 conditions by eHealthMe. Check the latest studies of Dry skin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

759 people reported to have side effects when taking Dimeticone.
Among them, 14 people (1.84%) have Dry skin.

Among these 14 people:

What is the gender of people who have Dry skin when taking Dimeticone? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Dry skin when taking Dimeticone? *

What are other drugs people take besides Dimeticone? *

Dupixent: 12 people, 85.71%
Proair Hfa: 3 people, 21.43%
Zyrtec: 2 people, 14.29%
Benicar: 2 people, 14.29%
Triamcinolone Acetonide: 2 people, 14.29%
Eucrisa: 2 people, 14.29%
Halobetasol Propionate: 1 person, 7.14%
Auryxia: 1 person, 7.14%
Biotin: 1 person, 7.14%
Breo Ellipta: 1 person, 7.14%

What are other side effects people have besides Dry skin? *

Itching: 8 people, 57.14%
Skin Exfoliation (removal of the oldest dead skin cells): 6 people, 42.86%
Therapeutic Response Decreased (less preventive response): 4 people, 28.57%
Skin Fissures (a crack in the skin): 3 people, 21.43%
Skin Discoloration: 2 people, 14.29%
Sleep Disorder: 2 people, 14.29%
Skin Disorder (skin disease): 1 person, 7.14%
Renal Disorder (kidney disease): 1 person, 7.14%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 7.14%
Joint Pain: 1 person, 7.14%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 14 people, 100.00%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 2 people, 14.29%
Rashes (redness): 1 person, 7.14%
Itching: 1 person, 7.14%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 7.14%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Dimeticone and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dimeticone:

Dimeticone (764 reports)

Dry skin treatments and more:

Dry skin (131,311 reports)

Browse all side effects of Dimeticone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Dry skin (1,977 drugs)

Browse all the conditions that are associated with Dry skin:

Dry skin (2,356 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simethicone (the active ingredients of Dimeticone) and Dimeticone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.